WEST LAFAYETTE, Ind., March 26, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that three poster presentations will be presented by Endocyte scientists at the 2012 Annual Meeting of the American Association for Cancer Research (AACR) to be held in Chicago, Ill., March 31 through April 4.
